AUTH/3082/9/18: Director v Bristol-Myers Squibb (Clinical trial disclosure) — Outwith scope / No breach | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/3082/9/18
Parties	Director v Bristol-Myers Squibb
Topic	Clinical trial disclosure
Complaint received	12 September 2018
Completed	03 July 2019
Applicable Code year	2016
Outcome	No breach
Clauses	Outwith the scope of the Code
Appeal	No appeal
Additional sanctions	Not stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

A matter was raised by the PMCPA Director concerning clinical trial disclosure involving Bristol-Myers Squibb.
The case was assessed under the ABPI Code of Practice 2016.
The PMCPA recorded the matter as outwith the scope of the Code.

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →